MAPT and Alzheimer disease: More importantly, we have reported that an in vivo convergence of tau and Aβ pathologies take place at AD mitochondria since the NH2htau synergically cooperates with Aβ species in inhibiting the oxidative phosphorylation synthesis of ATP, leading to the energy crisis and, eventually, neuronal deterioration [45].